Vanda Pharmaceuticals Inc. - Common Stock — 재무제표 (NASDAQ:VNDA) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 533.46 M593.79 M634.25 M648.44 M656.2 M488.95 M 총 부채 80.19 M88.86 M107.05 M103.53 M117.66 M161.76 M 자본금 총액 453.27 M504.93 M527.2 M544.91 M538.55 M327.19 M 총 부채 및 주주자본 533.46 M593.79 M634.25 M648.44 M656.2 M488.95 M 총부채 —————— 순부채 ——————

뉴스

Vanda: A Long-Term Pharma Growth Idea, Despite Q1 Earnings Miss (NASDAQ:VNDA)

Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Lags Revenue Estimates

Wall Street Analysts Predict a 105.03% Upside in Vanda (VNDA): Here's What You Should Know

Incyte (INCY) Beats Q1 Earnings and Revenue Estimates

AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics (ANAB)

Four Biotech Stocks Near Buy Points As Earnings Season Kicks In

반다 제약, Citizens Life Sciences 컨퍼런스에서 전략적 성장 통찰력 발표

Vanda Pharmaceuticals at The Citizens Life Sciences Conference: Strategic Growth Insights

Micron and Palantir among market cap stock movers on Tuesday

반다 파마슈티컬 주식, Truist, 약물 파이프라인에 ’매수’ 의견 제시

Truist initiates Vanda Pharmaceuticals stock at buy on drug pipeline

반다, 헤트리오즈 시차증 FDA 청문회 개최